Phase II: - treatment related toxicity [clinicaltrials_resource:8de663f3c60a51c226ae71577e0ec591]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Phase II: - treatment related toxicity [clinicaltrials_resource:8de663f3c60a51c226ae71577e0ec591]
Bio2RDF identifier
8de663f3c60a51c226ae71577e0ec591
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8de663f3c60a51c226ae71577e0ec591
measure [clinicaltrials_vocabulary:measure]
Phase II: - treatment related toxicity
identifier
clinicaltrials_resource:8de663f3c60a51c226ae71577e0ec591
title
Phase II: - treatment related toxicity
@en
type
label
Phase II: - treatment related ...... 663f3c60a51c226ae71577e0ec591]
@en